Dernières nouvelles
Information non disponible
The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications
Article de revueJ Mol Med (Berl), 2023.
Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report
Article de revueKidney Med, 5 (8), 2023.
Signaler des ajouts ou des modifications